1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Heart Failure and Reduced Ejection Fraction: new trials by email Literature Review of Heart Failure and Reduced Ejection Fraction trials Research Report on Heart Failure and Reduced Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction LCZ696 (sacubitril/valsartan), Enalapril, Placebo of Enalapril - Heart Failure and Reduced Ejection Fraction | Phase 4 | Completed | Novartis Pharmaceuticals | 465 | 2016-08-17 | 2021-01-05 |
Heart Failure (1) · Heart Failure, Systolic (1)
Cardiovascular Diseases (1) · Heart Diseases (1)
Enalapril (1) · Valsartan (1) · sacubitril (1) · sacubitril and valsartan sodium hydrate drug combination (1)
United States (1)
PMID 31475296, PMID 33663237, PMID 35115085, PMID 35560696, PMID 40678912